218 related articles for article (PubMed ID: 32496906)
41. Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways.
Li X; Yang Z; Han W; Lu X; Jin S; Yang W; Li J; He W; Qian Y
Int J Mol Med; 2017 Aug; 40(2):311-318. PubMed ID: 28586029
[TBL] [Abstract][Full Text] [Related]
42. Influence of Tanshinone IIA on apoptosis of human esophageal carcinoma Eca-109 cells and its molecular mechanism.
Zhang Y; Li S; He H; Han Q; Wang B; Zhu Y
Thorac Cancer; 2017 Jul; 8(4):296-303. PubMed ID: 28407361
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effect of Tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress.
Xie Z; Zhou Y; Duan X; Yang L
J Recept Signal Transduct Res; 2019 Apr; 39(2):134-145. PubMed ID: 31354004
[No Abstract] [Full Text] [Related]
44. Tanshinone IIA protected against lipopolysaccharide-induced brain injury through the protective effect of the blood-brain barrier and the suppression of oxidant stress and inflammatory response.
Wang X; Wang WM; Han H; Zhang Y; Liu JL; Yu JY; Liu HM; Liu XT; Shan H; Wu SC
Food Funct; 2022 Aug; 13(15):8304-8312. PubMed ID: 35839080
[TBL] [Abstract][Full Text] [Related]
45. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
Tang C; Xue HL; Huang HB; Wang XG
Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
[TBL] [Abstract][Full Text] [Related]
46. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.
Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
[TBL] [Abstract][Full Text] [Related]
47. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
48. Potential therapeutic roles of tanshinone IIA in human bladder cancer cells.
Chiu SC; Huang SY; Chang SF; Chen SP; Chen CC; Lin TH; Liu HH; Tsai TH; Lee SS; Pang CY; Hsieh TF
Int J Mol Sci; 2014 Sep; 15(9):15622-37. PubMed ID: 25192287
[TBL] [Abstract][Full Text] [Related]
49. Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a.
Chu Y; Fang Y; Chi J; Li J; Zhang D; Zou Y; Wang Z
Braz J Med Biol Res; 2018 Nov; 51(12):e7665. PubMed ID: 30462772
[TBL] [Abstract][Full Text] [Related]
50. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.
Lv C; Zeng HW; Wang JX; Yuan X; Zhang C; Fang T; Yang PM; Wu T; Zhou YD; Nagle DG; Zhang WD
Cell Death Dis; 2018 Feb; 9(2):165. PubMed ID: 29416003
[TBL] [Abstract][Full Text] [Related]
51. VS-5584 Inhibits Human Osteosarcoma Cells Growth by Induction of G1- phase Arrest through Regulating PI3K/mTOR and MAPK Pathways.
Sun JY; Hou YJ; Cui HJ; Zhang C; Yang MF; Wang FZ; Sun Z; Fan CD; Sun BL; Oh JR
Curr Cancer Drug Targets; 2020; 20(8):616-623. PubMed ID: 32286946
[TBL] [Abstract][Full Text] [Related]
52. Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of
Huang Y; Yu SH; Zhen WX; Cheng T; Wang D; Lin JB; Wu YH; Wang YF; Chen Y; Shu LP; Wang Y; Sun XJ; Zhou Y; Yang F; Hsu CH; Xu PF
Theranostics; 2021; 11(14):6891-6904. PubMed ID: 34093860
[No Abstract] [Full Text] [Related]
53. Tanshinone IIA exhibits anti-inflammatory and antioxidative effects in LPS-stimulated bovine endometrial epithelial cells by activating the Nrf2 signaling pathway.
Fu K; Feng C; Shao L; Mei L; Cao R
Res Vet Sci; 2021 May; 136():220-226. PubMed ID: 33689878
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of osteosarcoma cell proliferation in vitro and tumor growth in vivo in mice model by alstonine through AMPK-activation and PGC-1α/TFAM up-regulation.
Yan Q; Jiang J; Xie J; Jiang S; Bai Y
Acta Biochim Pol; 2022 Aug; 69(3):543-549. PubMed ID: 35975969
[TBL] [Abstract][Full Text] [Related]
55. Tanshinone IIa alleviates LPS-induced oxidative stress in dairy cow mammary epithelial cells by activating the Nrf2 signalling pathway.
Fu K; Sun Y; Wang J; Cao R
Res Vet Sci; 2022 Dec; 151():149-155. PubMed ID: 36027684
[TBL] [Abstract][Full Text] [Related]
56. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
[TBL] [Abstract][Full Text] [Related]
57. Protective effect of tanshinone IIA on H
Yang G; Wang F; Wang Y; Yu X; Yang S; Xu H; Xing J
J Recept Signal Transduct Res; 2020 Jun; 40(3):264-272. PubMed ID: 32100629
[TBL] [Abstract][Full Text] [Related]
58. Tanshinone ⅡA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling.
Li Y; Chen F; Guo R; Jia S; Li W; Zhang B
Biochem Biophys Res Commun; 2020 Jan; 522(1):157-163. PubMed ID: 31757424
[TBL] [Abstract][Full Text] [Related]
59. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
60. Tanshinone IIA prevents acetaminophen-induced nephrotoxicity through the activation of the Nrf2-Mrp2/4 pathway in mice.
Zhang X; Long F; Li R; Yang Y; Wang T; He Q; Xu M; Wang L; Jiang X
Environ Toxicol; 2022 Jul; 37(7):1618-1628. PubMed ID: 35243748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
